Janet Hopkins

Director Técnico/Científico/I+D en AURA BIOSCIENCES, INC. .

Fortuna: 1 M $ al 30/04/2024

59 años

Health Technology

Consumer Services

Cargos activos de Janet Hopkins

Empresas	Cargo	Inicio	Fin
GYROSCOPE THERAPEUTICS HOLDINGS PLC	Director/Miembro de la Junta	17/02/2022	-
AURA BIOSCIENCES, INC.	Director Técnico/Científico/I+D	16/10/2023	-

Empresas	Cargo	Inicio	Fin
NOVARTIS AG	Corporate Officer/Principal	01/11/2021	01/10/2023
Gyroscope Therapeutics Ltd. Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.	Director Ejecutivo	01/12/2021	01/10/2023

McMaster University

Doctorate Degree

Internacional

Operativa

Director/Board Member	1
Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1

Sectorial

Health Technology	5
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	2
AURA BIOSCIENCES, INC.	Health Technology
NOVARTIS AG	Health Technology

Empresas privadas	2
Gyroscope Therapeutics Holdings Plc Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom.	Health Technology
Gyroscope Therapeutics Ltd. Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.	Health Technology